PMHNP POST TEST NEWEST 2026 ACTUAL EXAM|
COMPLETE REAL EXAM QUESTIONS AND CORRECT
VERIFIED ANSWERS WITH RATIONALES/ ALREADY
GRADED A+ (MOST RECENT!!)
Q1: A patient with major depressive disorder (MDD) has
failed two SSRIs. Which of the following should the PMHNP
consider next?
A) Increase the dose of the most recent SSRI beyond the FDA
maximum
B) Switch to an SNRI (e.g., venlafaxine) or augment with
bupropion or mirtazapine
C) Discontinue all antidepressants and start monotherapy with
alprazolam
D) Begin electroconvulsive therapy (ECT) as first-line treatment
Answer: B
Rationale: After two failed SSRI trials, switching to an SNRI or
augmenting with bupropion or mirtazapine is
guideline-supported. ECT is not first-line.
1
,Q2: A patient presents with auditory hallucinations, paranoia,
and disorganized speech. Which of the following is the most
appropriate first-line antipsychotic?
A) Clozapine
B) Haloperidol
C) Risperidone or other second-generation antipsychotic (SGA)
D) Benztropine
Answer: C
Rationale: Second-generation antipsychotics (risperidone,
olanzapine, quetiapine, aripiprazole) are first-line for
first-episode psychosis. Clozapine is treatment-resistant.
Q3: Which of the following is the most serious adverse effect
of clozapine?
A) Weight gain
B) Diabetes
C) Agranulocytosis (severe neutropenia)
D) Sedation
Answer: C
Rationale: Agranulocytosis requires mandatory ANC monitoring.
2
,Weight gain and metabolic syndrome are common but not
immediately life-threatening.
Q4: A patient on lithium therapy develops nausea, coarse
tremor, ataxia, and confusion. The PMHNP should:
A) Increase the lithium dose
B) Check lithium level immediately (suspect toxicity) and hold
lithium
C) Add propranolol for tremor
D) Switch to valproate without checking level
Answer: B
Rationale: Nausea, coarse tremor, ataxia, and confusion are
signs of lithium toxicity. Check level, hold lithium, assess renal
function.
Q5: Which of the following baseline assessments is required
before starting clozapine?
A) Absolute neutrophil count (ANC) and white blood cell (WBC)
B) Liver function tests only
C) Thyroid panel only
D) Electrocardiogram only
3
, Answer: A
Rationale: ANC and WBC are required before clozapine
initiation and throughout treatment per REMS requirement to
monitor for agranulocytosis.
Q6: The first-line pharmacologic treatment for generalized
anxiety disorder (GAD) is:
A) Alprazolam
B) Buspirone (second-line) or SSRI/SNRI (first-line)
C) Propranolol
D) Quetiapine
Answer: B (SSRI/SNRI first-line)
Rationale: SSRIs and SNRIs (e.g., escitalopram, duloxetine) are
first-line for GAD. Buspirone is also effective but often
second-line. Benzodiazepines should be avoided for long-term
use.
Q7: A patient on fluoxetine develops serotonin syndrome.
Which of the following findings is characteristic?
A) Bradycardia and hypotension
B) Hyperreflexia, clonus, agitation, diaphoresis
4
COMPLETE REAL EXAM QUESTIONS AND CORRECT
VERIFIED ANSWERS WITH RATIONALES/ ALREADY
GRADED A+ (MOST RECENT!!)
Q1: A patient with major depressive disorder (MDD) has
failed two SSRIs. Which of the following should the PMHNP
consider next?
A) Increase the dose of the most recent SSRI beyond the FDA
maximum
B) Switch to an SNRI (e.g., venlafaxine) or augment with
bupropion or mirtazapine
C) Discontinue all antidepressants and start monotherapy with
alprazolam
D) Begin electroconvulsive therapy (ECT) as first-line treatment
Answer: B
Rationale: After two failed SSRI trials, switching to an SNRI or
augmenting with bupropion or mirtazapine is
guideline-supported. ECT is not first-line.
1
,Q2: A patient presents with auditory hallucinations, paranoia,
and disorganized speech. Which of the following is the most
appropriate first-line antipsychotic?
A) Clozapine
B) Haloperidol
C) Risperidone or other second-generation antipsychotic (SGA)
D) Benztropine
Answer: C
Rationale: Second-generation antipsychotics (risperidone,
olanzapine, quetiapine, aripiprazole) are first-line for
first-episode psychosis. Clozapine is treatment-resistant.
Q3: Which of the following is the most serious adverse effect
of clozapine?
A) Weight gain
B) Diabetes
C) Agranulocytosis (severe neutropenia)
D) Sedation
Answer: C
Rationale: Agranulocytosis requires mandatory ANC monitoring.
2
,Weight gain and metabolic syndrome are common but not
immediately life-threatening.
Q4: A patient on lithium therapy develops nausea, coarse
tremor, ataxia, and confusion. The PMHNP should:
A) Increase the lithium dose
B) Check lithium level immediately (suspect toxicity) and hold
lithium
C) Add propranolol for tremor
D) Switch to valproate without checking level
Answer: B
Rationale: Nausea, coarse tremor, ataxia, and confusion are
signs of lithium toxicity. Check level, hold lithium, assess renal
function.
Q5: Which of the following baseline assessments is required
before starting clozapine?
A) Absolute neutrophil count (ANC) and white blood cell (WBC)
B) Liver function tests only
C) Thyroid panel only
D) Electrocardiogram only
3
, Answer: A
Rationale: ANC and WBC are required before clozapine
initiation and throughout treatment per REMS requirement to
monitor for agranulocytosis.
Q6: The first-line pharmacologic treatment for generalized
anxiety disorder (GAD) is:
A) Alprazolam
B) Buspirone (second-line) or SSRI/SNRI (first-line)
C) Propranolol
D) Quetiapine
Answer: B (SSRI/SNRI first-line)
Rationale: SSRIs and SNRIs (e.g., escitalopram, duloxetine) are
first-line for GAD. Buspirone is also effective but often
second-line. Benzodiazepines should be avoided for long-term
use.
Q7: A patient on fluoxetine develops serotonin syndrome.
Which of the following findings is characteristic?
A) Bradycardia and hypotension
B) Hyperreflexia, clonus, agitation, diaphoresis
4
